Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on April 19, 2026

Apr. 19, 2026

Akribis Veins & Vitality Introduces Pelvic Floor Refresh Program Combining EmSella and EmSculpt Neo

Indeterminate EIN Presswire

Apr. 19, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Indeterminate GlobeNewswire

Apr. 19, 2026

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Indeterminate GlobeNewswire

Apr. 19, 2026

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Indeterminate GlobeNewswire

Apr. 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

Indeterminate GlobeNewswire

Apr. 19, 2026

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire

Apr. 19, 2026

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026

Indeterminate GlobeNewswire

Apr. 19, 2026

Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 19, 2026

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

Indeterminate GlobeNewswire